Lupuzor™ is an in-development treatment for Lupus, a chronic inflammatory disease thought to affect around 5 million people worldwide. Having ...Read more >
Simbec-Orion recently helped a biotech sponsor demonstrate the safety and tolerability of a new trial treatment for idiopathic pulmonary fibrosis ...Read more >
In previous years, pharmacology and clinical trials were topics which mainly interested medical professionals, rather than the public. However, as ...Read more >
A scintigraphy study of budesonide/ glycopyrrolate/ formoterol fumarate metered dose inhaler in patients with moderate‑to‑very severe chronic obstructive pulmonary disease. ...Read more >
If you think we could be right for you, get in touch.